How big is Axsome Therapeutics, Inc.?

Jun 22 2025 05:48 PM IST
share
Share Via
As of Jun 18, Axsome Therapeutics, Inc. has a market capitalization of $5.00 billion, with net sales of $432.16 million and a net profit of -$278.26 million over the last four quarters. The company reported shareholder's funds of $57.02 million and total assets of $568.50 million as of Dec 24.
Market Cap: As of Jun 18, Axsome Therapeutics, Inc. has a market capitalization of 5,002.41 million, categorizing it as a Small Cap company.

Recent Quarterly Performance: For the latest four quarters, Axsome Therapeutics, Inc. reported net sales of 432.16 million and a net profit of -278.26 million.

Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 57.02 million and total assets of 568.50 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Axsome Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:03 PM IST
share
Share Via
Is Axsome Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 08:38 AM IST
share
Share Via
What does Axsome Therapeutics, Inc. do?
Jun 22 2025 06:23 PM IST
share
Share Via